Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich Plasma in Knee Osteoarthritis
NCT04754685Completed
- Sponsor
- South Valley University
- Start
- Feb 2019
- Primary completion
- Jan 2020
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Open-label trial of platelet-rich plasma in knee osteoarthritis (OA) (3 arms), sponsored by South Valley University. Primary endpoints: Pain Score at 4 weeks, Tumor necrosis factor-α at 4 weeks and 2 more. Started Feb 2019; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04754685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04754685.